ESSA PHARMA INC

EPIX11 Dec 2024
Healthcare
$1.7
-0.01 (-0.59%)
Lowest Today
$1.68
Highest Today
$1.74
Today’s Open
$1.7
Prev. Close
$1.7
52 Week High
$11.67
52 Week Low
$1.4
BUY
SELL
To Invest in ESSA PHARMA INC

ESSA PHARMA INC

Healthcare
EPIX11 Dec 2024
₹
-0.01 (-0.59%)
1M
3M
6M
1Y
5Y
Low
$1.68
Day’s Range
High
$1.74
1.68
52 Week Low
$1.4
52-Week Range
52 Week High
$11.67
1.4
1 Day
-
1 Week
-
1 month return
-7.1%
3 month return
-75.71%
6 month return
-66.92%
1 Year return
-68.34%
3 Years return
-85.9%
5 Years return
-70.22%
10 Years return
-
Institutional Holdings
Bvf Inc
19.71
BB Biotech AG Ord
17.75
Bellevue Group AG
17.75
Soleus Capital Management, L.P.
9.66
Morgan Stanley - Brokerage Accounts
9.42
RTW INVESTMENTS, LLC
7.35
Partner Fund Management LP
6.18

Market Status

Fundamentals
Market Cap
75.46 mln
PB Ratio
0.59
PE Ratio
0
Enterprise Value
-54.89 mln
Total Assets
149.12 mln
Volume

Company Financials

Fund house & investment objective

Company Information
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Organisation
ESSA PHARMA INC
Employees
50
Industry
Biotechnology
CEO
Dr. David Ross Parkinson M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Get expert assistance for portfolio management

BUY
SELL